Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gitlab Inc (GTLB) vs Lemonade Inc (LMND) Price & Performance

Gitlab IncTrade
Lemonade IncTrade

Price performance (Past 24H)

Key statistics

Gitlab Inc vs Lemonade Inc — how do they compare? Gitlab Inc trades at $55.09 (market cap $8.92B), while Lemonade Inc trades at $46.46 (market cap $3.63B). The key difference: Gitlab Inc is far larger — about 2.5× Lemonade Inc's market cap, and Gitlab Inc is trading nearer its 52-week high, Lemonade Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Gitlab Inc for 62 Days and Lemonade Inc for 27 Days on average.

GTLBLMND
Market Cap
$8.92B$3.63B
Volume
4,716,8931,544,794
Sector
TechnologyFinancials
52-Week High
$53.56$96.57
52-Week Low
$19.42$43.91
Typical Hold Time
62 Days27 Days
Enterprise Value
$7.66B$3.49B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gitlab Inc

GitLab (GTLB) trades at $53.56, up 3.02% today and near its 52-week high, with strong technical momentum indicated by moving averages. The company shows impressive revenue growth, reaching $759 million in 2025, but remains unprofitable with a negative net income margin of -4.99%. Recent Q2 2026 earnings beat expectations, and the stock surged on raised guidance and AI-driven demand optimism.

Outlook: GitLab benefits from AI integration in software development and strong sales momentum, but high valuation multiples (P/E 521) and persistent losses pose risks. Analyst consensus is mixed with a $49.71 price target below current levels, suggesting cautious optimism amid execution challenges and competitive pressures.

Lemonade Inc

Lemonade (LMND) trades at $46.91, up 0.17% on the day, with a bearish technical signal driven by moving averages. The company shows strong revenue growth, with 2025 revenue reaching $738 million, and net losses narrowing to -$166 million. Recent news highlights expansion into new states and AI-driven efficiency gains, with management targeting EBITDA profitability by late 2026.

The outlook is mixed: growth and margin improvement offer upside, but persistent losses and high valuation multiples pose risks. Analysts are divided with a consensus price target of $67, suggesting potential upside if profitability targets are met. Key risks include execution on profitability and competitive pressures in the insurtech space.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GTLB
100% Buy0% Sell
Avg holding period · 62 Days
LMND

No sentiment data available yet.

Top news

Latest headlines on both assets

About Gitlab Inc

GitLab Inc operates on an all-remote model. The company is a technology company whose primary offering is GitLab, a complete DevOps platform delivered as a single application. GitLab is used by a wide range of organizations. The company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world.

Read more on GTLB →

About Lemonade Inc

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.

Read more on LMND →